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Abstract. Radiation therapy is one of the cornerstones of 
modern multidisciplinary cancer treatment. Normal tissue 
tolerance is critical as radiation-induced side effects may 
compromise organ function and quality of life. The importance 
of normal tissue research is reflected by the large number of 
scientific articles, which have been published between 2006 
and 2010. The present study identified important areas of 
research as well as seminal publications. The article citation 
rate is among the potential indicators of scientific impact. 
Highly cited articles, arbitrarily defined as those with ≥15 cita-
tions, were identified via a systematic search of the citation 
database, Scopus. Up to 608 articles per year were published 
between 2006 and 2010, however, <10% of publications in each 
year accumulated ≥15 citations. This figure is notably low, 
when compared with other oncology studies. A large variety 
of preclinical and clinical topics, including toxicity prediction, 
the dose-volume relationship and radioprotectors, accumu-
lated ≥15 citations. However, clinical prevention or mitigation 
studies were underrepresented. The following conclusion may 
be drawn from the present study; despite the improved tech-
nology that has resulted in superior dose distribution, clinical 
prevention or mitigation studies are critical and must receive 
higher priority, funding and attention.
Introduction
Due to the infiltrative nature of malignant tumors and the 
resulting requirement for safety margins surrounding macro-
scopic lesions, as well as tumor motion and set‑up variations, 
radiation treatment inevitably influences surrounding normal 
tissues. Due to the potentially serious consequences of normal 
tissue damage, significant investigations have been directed 
towards improving the therapeutic index (1‑4). As a result 
of feedback from previous studies, clinical studies regarding 
normal tissue (including those concerning long-term cardio-
vascular disease or neurotoxicity) were considered to be 
difficult to perform due to the requirement for long-term 
follow‑up, a rigorous methodology and large patient numbers, 
in addition to being costly (5‑7). The aim of the present study 
was to quantify this assumption in a systematic review of the 
literature by identifying the particularly influential scientific 
publications as well as the areas that are currently predomi-
nantly being investigated. For various reasons, including 
(although not limited to) tenure track or probability of future 
funding, study groups attempt to publish their results in a way 
that ensures high visibility and allows for the broad adoption 
of the progress achieved. The success of a publication may be 
defined by various factors. The impact factor of journals is 
a double‑edged sword, for example in publication bias exists, 
where negative or inconclusive studies are not reported (8‑10). 
Article download rates may provide an indication of visibility 
and impact; however, this depends on the presence and the 
amount of fees that are charged by the publisher. Another 
potential measure of the quality and impact of studies is the 
citation rate (11,12). Notable or practice‑changing studies are 
likely to be cited by follow‑up trials, editorials and review 
articles. The citation rates of articles published between 2006 
and 2010 were evaluated for the purpose of the present study. 
Information regarding highly cited article types may facilitate 
strategic decision‑making and preparation of future research 
projects. Furthermore, identifying underrepresented research 
areas may initiate the improvement of resource allocation and 
increase the focus on these areas.
Materials and methods
Data source, search strategy and inclusion criteria. On 
November 7, 2012, a systematic search of the database, Scopus 
(Elsevier B.V.; www.scopus.com) using the key words ‘normal 
tissue’ and ‘radiotherapy’ was performed. The evolution of 
publication activity following the year 2000 was analyzed 
in order to provide a broader view of the subject. Articles, 
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including reviews, and clinical and experimental studies, 
published between 2006 and 2010 were selected regardless 
of language and article type. Pure dosimetric studies, for 
example those comparing normal tissue doses with photons 
versus protons (treatment planning without clinical follow‑up 
data) were excluded. 
Analysis of patterns of citation. Finally, patterns of citation 
(using the field, ‘times cited’ in the Scopus citation database) 
were analyzed as described in our previous study (13). The 
total number of accumulated citations was evaluated (irre-
spective of their origin) and the proportion of highly cited 
articles, arbitrarily defined as those with ≥25 citations, was 
investigated. Due to the notably low number of such articles, 
the cut‑off was lowered to ≥15 citations. A complete list of 
articles that have been cited ≥15 times may be requested from 
the corresponding author.
Statistical analysis. To estimate the longitudinal trends, the 
estimated annual percentage change was calculated by use of 
a linear regression model (IBM SPSS Statistics 21, Armonk, 
NY, USA). Statistical significance was assessed using the 
two‑tailed test. P<0.05 was considered to indicate a statisti-
cally significant difference.
Results
Review of the literature. Between 482 and 608 articles per year 
were published during the five‑year period that was investi-
gated. Fig. 1 presents the number of publications per year, 
which significantly increased between 2006 and 2010 by >50% 
(P>0.05). In each year <10% of publications accumulated ≥15 
citations. Fig. 1 also shows that accumulation of citations 
takes ≥3‑4 years subsequent to publication. Therefore, articles 
published in 2009 and 2010 were less likely to have accumu-
lated ≥15 citations.
Most cited references. References (14‑38) represent the five 
most cited articles annually between 2006 and 2010. The most 
cited articles were published in 12 different scientific journals. 
Ten articles (40%) were published in the International Journal 
of Radiation Oncology Biology and Physics, and two (8%) in 
each of the Journal of Clinical Oncology, Radiotherapy and 
Oncology, Nature Reviews Cancer and Oncologist. Table I 
shows the 10 most cited articles overall. The majority of 
these were reviews or radiobiological modeling studies and 
all but three were published prior to 2009. Since articles that 
were published, for example, in 2006 are more likely to have 
accumulated a large number of citations than articles that were 
published in 2010, the mean of the annual numbers of citations 
was also calculated. For this purpose, 2012 was defined as 
0.85 years (January 1st‑November 7th). Table II displays the 
10 articles with the most citations per year and contains articles 
that were published between 2006 and 2010. The majority of 
these were also reviews or radiobiological modeling studies.
Discussion
The aim of the current study was to identify influential and 
highly cited scientific publications (thereby determining the 
trends in current research) concerning the pathogenesis, epide-
miology, prevention, diagnosis, and treatment of normal tissue 
toxicity during the five‑year period between 2006 and 2010. It 
was hypothesized that large, clinical toxicity prevention or miti-
gation studies may complement the technical efforts towards 
improved dose distribution and organ sparing, and improve 
quality of life of irradiated cancer survivors. However, large, 
clinical toxicity prevention or mitigation studies are difficult 
to conduct due to cost issues and competition for funding, 
thus, are rare and relatively underrepresented. Following 
arbitrary decisions regarding which database to search and 
what keywords to use, a systematic literature search was 
performed and a broad definition of normal tissue‑associated 
publications was applied (excluding pure treatment planning 
studies without clinical follow‑up data). The citation rate of 
published articles was subsequently evaluated. Articles that 
have accumulated a high number of citations are likely to have 
impressed other clinicians/scientists and, thus, may profoundly 
influence clinical practice or future developments in the field.
The number of studies performed has increased in the 
time period that was studied in the present study. In contrast 
to general radiotherapy publications (39), none of the articles 
regarding normal tissues achieved >40 citations per year. In 
our previous study, 15% of all articles accumulated ≥40 cita-
tions per year and 42% had between 20 and 39. Most citations 
per year were recorded for meta‑analyses and randomized 
phase III trials. Notably, the lowest figures were observed 
for review articles, non‑phase III prospective clinical trials 
and retrospective clinical studies (39). In a recent review of 
glioblastoma research, the ten articles with the highest number 
of citations were cited ≥100 times annually (13). Only 1.5% 
of all glioblastoma articles published between 2006 and 2010 
accumulated ≥100 citations, however, ~10% had 25‑99 cita-
tions. In a previous study regarding radiosurgery for various 
conditions the same figure was reported (40); this particular 
study did not include articles with <100 citations. To the best 
of our knowledge, no other published citation studies have 
focused on normal tissue research. The results of the present 
study indicate that considerable differences exist with regards 
to the topics mentioned above.
Figure 1. Number of articles published annually. The percentages displayed 
represent the red bars.
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In addition to the absolute number of citations, the mean 
annual citation rate was also evaluated as the exact time course 
or kinetics of citation are difficult to predict, and vary with 
the topic and journal (41). The accumulation of citations of 
recently published articles and the reduced interest in older 
articles over time presents a challenge if reliable quantitative 
analysis is to be attempted. The current study did not account 
for the date of publication in terms of whether an article 
was published earlier or later during a specific year. For the 
purpose of this study, the selected methods were considered 
to be sufficient. However, more detailed and quantitative 
analyses may be performed with the internet‑based tools avail-
able. It must be noted that searches using different databases or 
different key words may result in more or less variable citation 
counts; therefore, the present results only provide a snapshot. 
Furthermore, self‑citation is likely to influence the final cita-
tion count of sparsely cited articles, whereas its impact on 
highly cited articles may be less pronounced. It was recently 
estimated that 6.4% of all citations per article (interquartile 
range, 2.8‑11.3; mean, 8.4) were self‑citations (42). The studies 
most vulnerable to this effect were those with a higher number 
of authors and small sample sizes.
The results of the present study are consistent with the 
theory that citation rate progressively increases several years 
after publication. However, the aim of the present study was 
not to investigate the dynamics of citation counts. As the 
majority of scientific radiation oncology journals have steadily 
increased in numbers of published issues and articles, and 
considering that each article contains a certain number of 
references, the increase in total publication numbers over time 
is expected to result in a parallel increase in citation rates. 
Notably, the highly cited studies were published in a large 
number of different scientific journals with or without high 
impact factors and were always in English.
Between 2006 and 2010, significant progress has been 
achieved in the areas of genomic analyses, toxicity predic-
tion and implementation of highly conformal radiotherapy 
techniques, which reduce normal tissue doses. Various articles 
regarding these subjects were among those with the highest 
numbers of citations (13,26,27,31,32). Systematic reviews were 
also considered likely to achieve a high number of citations. 
The large diversity of current research topics covering all clin-
ical, pre‑clinical, biological and technical aspects of the field 
is noteworthy. Prospective clinical research in areas including 
Table I. Ten articles with the highest number of citations (absolute count).
Author, year  Absolute citation Citations per
(reference) Short title count year
Bentzen 2006 (14) Review of late effects 154 22
François et al 2006 (15) Human mesenchymal stem cell engraftment 123 18
Kong et al 2006 (16) Radiation pneumonitis and fibrosis 112 16
Wazer et al 2006 (17) Late toxicity after breast radiotherapy   90 13
Fiorino et al 2009 (29) Pelvic normal tissue review   67 17
Bentzen and Trotti 2007 (19) Toxicity of chemoradiation review   66 11
Barnett et al 2009 (30) Tailoring dose by genotype   65 17
Kouvaris et al 2007 (20) Amifostine review   60 10
Kirkpatrick et al 2008 (24) LQ model in radiosurgery   60 12
Michalski et al 2010 (34) Dose‑volume effects for rectum   60 21
Table II. Articles with the highest number of annual citations.
Author, year  Citations per Absolute citation
(reference) Short title year count
Bentzen 2006 (114) Review of late effects 22 154
Michalski et al 2010 (34) Dose‑volume effects for rectum 21   60
François et al 2006 (15) Human mesenchymal stem cell engraftment 18 123
Fiorino et al 2009 (29) Pelvic normal tissue review 17   67
Barnett et al 2009 (30) Tailoring dose by genotype 17   65
Kong et al 2006 (16) Radiation pneumonitis and fibrosis 16 112
Bentzen et al 2010 (35) QUANTEC review 15   44
Weiss and Landauer 2009 (31) Review of radioprotectors 15   59
Zhao and Robbins 2009 (32) Inflammation and chronic oxidative stress in 14   53
 late normal tissue injury
Wazer et al 2006 (17) Late toxicity after breast radiotherapy 13 90
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prevention and mitigation, using radioprotectors and response 
modifiers, was underrepresented. This is unusual considering 
the major focus on radiation‑induced long‑term effects in breast 
cancer, lymphoma and brain cancer survivors (43‑45). Efforts 
to support awareness, funding and publication of normal tissue 
studies, in particular clinical strategies that aim to reduce 
toxicity and improve quality of life, may be warranted.
In conclusion, publication numbers have increased in recent 
years; however, the number of highly cited articles is limited. 
In addition to the dose-volume relationship and pathogenesis of 
normal tissue effects, the predominating research areas were 
genomic analyses and toxicity prediction. For clinical practice, 
the development of effective prevention and mitigation strategies 
is required, as improvements in technology alone cannot prevent 
all types of radiation‑induced toxicity. Radiation fields inevitably 
include certain amounts of normal tissue, however, current 
clinical studies primarily focus on cancer cells and efforts to 
increase their radiosensitivity. Thus, general support and funding 
for clinical studies focusing on normal tissues are required.
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